Federated Hermes’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-585
| Closed | -$1.39K | – | 2172 |
|
|
2023
Q4 | $1.39K | Sell |
585
-1,123
| -66% | -$2.66K | ﹤0.01% | 1952 |
|
|
2023
Q3 | $2.39K | Buy |
+1,708
| New | +$2.39K | ﹤0.01% | 1955 |
|
|
2023
Q1 | – | Sell |
-4
| Closed | -$24 | – | 2296 |
|
|
2022
Q4 | $24 | Sell |
4
-307,796
| -100% | -$1.85M | ﹤0.01% | 2136 |
|
|
2022
Q3 | $3.68M | Hold |
307,800
| – | – | 0.01% | 742 |
|
|
2022
Q2 | $3.88M | Hold |
307,800
| – | – | 0.01% | 749 |
|
|
2022
Q1 | $3.47M | Hold |
307,800
| – | – | 0.01% | 870 |
|
|
2021
Q4 | $5.45M | Hold |
307,800
| – | – | 0.01% | 789 |
|
|
2021
Q3 | $7.09M | Hold |
307,800
| – | – | 0.01% | 740 |
|
|
2021
Q2 | $7.17M | Hold |
307,800
| – | – | 0.01% | 745 |
|
|
2021
Q1 | $9.59M | Buy |
307,800
+57,800
| +23% | +$1.8M | 0.02% | 669 |
|
|
2020
Q4 | $9.95M | Buy |
+250,000
| New | +$9.95M | 0.02% | 641 |
|